These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2521411

  • 1. Variation in patient response associated with different preparations of murine monoclonal antibody therapy.
    Delmonico FL, Fuller TC, Russell PS, Colvin RB, Cosimi AB.
    Transplantation; 1989 Jan; 47(1):92-5. PubMed ID: 2521411
    [Abstract] [Full Text] [Related]

  • 2. Fc-receptor for mouse IgG1 (Fc gamma RII) and antibody-mediated cell clearance in patients treated with Leu2a antibody.
    Wee SL, Colvin RB, Phelan JM, Preffer FI, Reichert TA, Berd D, Cosimi AB.
    Transplantation; 1989 Dec; 48(6):1012-7. PubMed ID: 2531948
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
    Jaffers GJ, Fuller TC, Cosimi AB, Russell PS, Winn HJ, Colvin RB.
    Transplantation; 1986 May; 41(5):572-8. PubMed ID: 3085297
    [Abstract] [Full Text] [Related]

  • 4. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
    Woodle ES, Thistlethwaite JR, Jolliffe LK, Fucello AJ, Stuart FP, Bluestone JA.
    Transplantation; 1991 Aug; 52(2):361-8. PubMed ID: 1714644
    [Abstract] [Full Text] [Related]

  • 5. Cross-species reactivity of the anti-idiotype anti-OKT3 cascade between mice and humans.
    Carreno M, Fuller L, Zucker K, Yang WC, Burke G, Nery J, Gomez C, Esquenazi V, Miller J.
    Hum Immunol; 1992 Apr; 33(4):249-58. PubMed ID: 1386353
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen.
    van Dijk J, Warnaar SO, van Eendenburg JD, Thienpont M, Braakman E, Boot JH, Fleuren GJ, Bolhuis RL.
    Int J Cancer; 1989 Feb 15; 43(2):344-9. PubMed ID: 2521843
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation.
    Millis JM, McDiarmid SV, Hiatt JR, Brems JJ, Colonna JO, Klein AS, Ashizawa T, Hart J, Lewin K, Goldstein LI.
    Transplantation; 1989 Jan 15; 47(1):82-8. PubMed ID: 2521409
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
    Kaminski MS, Kitamura K, Maloney DG, Campbell MJ, Levy R.
    J Immunol; 1986 Feb 01; 136(3):1123-30. PubMed ID: 3484499
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rejection prophylaxis with sequential OKT3 and CSA after kidney transplantation.
    Weimar W, Hesse CJ, Vaessen LM, Hendriks GF, Jutte NH, Jeekel J.
    Biotherapy; 1990 Feb 01; 2(3):267-70. PubMed ID: 1698424
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Idiotype switching of CD4-specific monoclonal antibodies can prolong the therapeutic effectiveness in spite of host anti-mouse IgG antibodies.
    Jonker M, Den Brok JH.
    Eur J Immunol; 1987 Nov 01; 17(11):1547-53. PubMed ID: 3500064
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.
    Chatenoud L, Baudrihaye MF, Chkoff N, Kreis H, Goldstein G, Bach JF.
    J Immunol; 1986 Aug 01; 137(3):830-8. PubMed ID: 3487589
    [Abstract] [Full Text] [Related]

  • 20. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
    Demanet C, Brissinck J, Van Mechelen M, Leo O, Thielemans K.
    J Immunol; 1991 Aug 01; 147(3):1091-7. PubMed ID: 1830596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.